Triple
T3803132
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Stuart L. Schreiber |
E91736
|
entity |
| Predicate | coFounderOf |
P104
|
FINISHED |
| Object |
Ariad Pharmaceuticals
Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
|
E387618
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Ariad Pharmaceuticals | Statement: [Stuart L. Schreiber, coFounderOf, Ariad Pharmaceuticals]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ariad Pharmaceuticals Context triple: [Stuart L. Schreiber, coFounderOf, Ariad Pharmaceuticals]
-
A.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
-
B.
Idera, Inc.
Idera, Inc. is a software company best known for its database management, performance monitoring, and developer tools used by IT professionals and enterprises.
-
C.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
D.
Elan Pharmaceuticals
Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
-
E.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Ariad Pharmaceuticals Triple: [Stuart L. Schreiber, coFounderOf, Ariad Pharmaceuticals]
Generated description
Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Ariad Pharmaceuticals Target entity description: Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
-
A.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
-
B.
Idera, Inc.
Idera, Inc. is a software company best known for its database management, performance monitoring, and developer tools used by IT professionals and enterprises.
-
C.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
D.
Elan Pharmaceuticals
Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
-
E.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69aed96354f48190a768966d6bd19b04 |
completed | March 9, 2026, 2:29 p.m. |
| NER | Named-entity recognition | batch_69aee7bacf2881908198a77063d15d16 |
completed | March 9, 2026, 3:31 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b4f06889c88190ab4d8da7f0dfeadd |
completed | March 14, 2026, 5:21 a.m. |
| NEDg | Description generation | batch_69b4f0e77efc8190b4459d4559261a2f |
completed | March 14, 2026, 5:23 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69b4f15cfde88190bcb2680b90f98111 |
completed | March 14, 2026, 5:25 a.m. |
Created at: March 9, 2026, 3:15 p.m.